Pterostilbene alleviated cerebral ischemia/reperfusion-induced blood–brain barrier dysfunction via inhibiting early endothelial cytoskeleton reorganization and late basement membrane degradation
Open Access
- 21 August 2023
- journal article
- research article
- Published by Royal Society of Chemistry (RSC) in Food & Function
- Vol. 14 (18) , 8291-8308
Abstract
Pterostilbene, an important analogue of the star molecule resveratrol and a novel compound naturally occurring in blueberries and grapes, exerts a significant neuroprotective effect on cerebral ischemia/reperfusion (I/R), but its mechanism is still unclear. This study aimed to follow the molecular mechanisms behind the potential protective effect of pterostilbene against I/R induced injury. For fulfilment of our aim, we investigated the protective effects of pterostilbene on I/R injury caused by middle cerebral artery occlusion (MCAO) in vivo and oxygen-glucose deprivation (OGD) in vitro. Machine learning models and molecular docking were used for target exploration and validated by western blotting. Pterostilbene significantly reduced the cerebral infarction volume, improved neurological deficits, increased cerebral microcirculation and improved blood–brain barrier (BBB) leakage. Machine learning models confirmed that the stroke target MMP-9 bound to pterostilbene, and molecular docking demonstrated the strong binding activity. We further found that pterostilbene could depolymerize stress fibers and maintain the cytoskeleton by effectively increasing the expression of the non-phosphorylated actin depolymerizing factor (ADF) in the early stage of I/R. In the late stage of I/R, pterostilbene could activate the Wnt pathway and inhibit the expression of MMP-9 to decrease the degradation of the extracellular basement membrane (BM) and increase the expression of junction proteins. In this study, we explored the protective mechanisms of pterostilbene in terms of both endothelial cytoskeleton and extracellular matrix. The early and late protective effects jointly maintain BBB stability and attenuate I/R injury, showing its potential to be a promising drug candidate for the treatment of ischemic stroke.Keywords
Funding Information
- Natural Science Foundation of Beijing Municipality (7173267)
- National Natural Science Foundation of China (81473579, 81973744)
This publication has 79 references indexed in Scilit:
- Protective effect of Pterostilbene against free radical mediated oxidative damageBMC Complementary and Alternative Medicine, 2013
- The Inhibitory Effect of Pterostilbene on Inflammatory Responses during the Interaction of 3T3-L1 Adipocytes and RAW 264.7 MacrophagesJournal of Agricultural and Food Chemistry, 2013
- Stroke research at a crossroad: asking the brain for directionsNature Neuroscience, 2011
- In vitro evaluation of the cytotoxic, anti-proliferative and anti-oxidant properties of pterostilbene isolated from Pterocarpus marsupiumToxicology in Vitro, 2010
- Anti-inflammatory Action of Pterostilbene Is Mediated through the p38 Mitogen-Activated Protein Kinase Pathway in Colon Cancer CellsCancer Prevention Research, 2009
- Caveolae-mediated Internalization of Occludin and Claudin-5 during CCL2-induced Tight Junction Remodeling in Brain Endothelial CellsJournal of Biological Chemistry, 2009
- The actin cytoskeleton in endothelial cell phenotypesMicrovascular Research, 2009
- Formation of the blood–brain barrier: Wnt signaling seals the dealJournal of Cell Biology, 2008
- Wnt/β-catenin signaling controls development of the blood–brain barrierJournal of Cell Biology, 2008
- The Lausanne Stroke Registry: analysis of 1,000 consecutive patients with first stroke.Stroke, 1988